BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35637404)

  • 1. Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis.
    Giacalone VD; Moncada-Giraldo D; Margaroli C; Brown MR; Silva GL; Chandler JD; Peng L; Tirouvanziam R; Guglani L;
    Pediatr Pulmonol; 2022 Sep; 57(9):2189-2198. PubMed ID: 35637404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.
    McGarvey LP; Dunbar K; Martin SL; Brown V; Macmahon J; Ennis M; Elborn JS
    J Cyst Fibros; 2002 Dec; 1(4):269-75. PubMed ID: 15463826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL.
    Reinhardt N; Chen CI; Loppow D; Schink T; Kleinau I; Jörres RA; Wahn U; Magnussen H; Paul KP
    Eur Respir J; 2003 Sep; 22(3):497-502. PubMed ID: 14516141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.
    Fantino E; Gangell CL; Hartl D; Sly PD;
    BMC Pulm Med; 2014 Feb; 14():28. PubMed ID: 24576297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
    Armstrong DS; Hook SM; Jamsen KM; Nixon GM; Carzino R; Carlin JB; Robertson CF; Grimwood K
    Pediatr Pulmonol; 2005 Dec; 40(6):500-10. PubMed ID: 16208679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
    Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
    Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF.
    Horati H; Margaroli C; Chandler JD; Kilgore MB; Manai B; Andrinopoulou ER; Peng L; Guglani L; Tiddens HAMW; Caudri D; Scholte BJ; Tirouvanziam R; Janssens HM
    J Cyst Fibros; 2024 May; 23(3):450-456. PubMed ID: 38246828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis.
    Gutierrez JP; Grimwood K; Armstrong DS; Carlin JB; Carzino R; Olinsky A; Robertson CF; Phelan PD
    Eur Respir J; 2001 Feb; 17(2):281-6. PubMed ID: 11334132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared.
    Pizzichini E; Pizzichini MM; Kidney JC; Efthimiadis A; Hussack P; Popov T; Cox G; Dolovich J; O'Byrne P; Hargreave FE
    Eur Respir J; 1998 Apr; 11(4):828-34. PubMed ID: 9623684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis.
    Montgomery ST; Dittrich AS; Garratt LW; Turkovic L; Frey DL; Stick SM; Mall MA; Kicic A;
    J Cyst Fibros; 2018 Nov; 17(6):715-722. PubMed ID: 29884450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis.
    McElvaney OJ; Gunaratnam C; Reeves EP; McElvaney NG
    J Cyst Fibros; 2019 Mar; 18(2):203-211. PubMed ID: 29960875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of bronchoalveolar lavage and its influence factors in the treatment of
    Yang M; Yang DH; Yang X; Wang YS; Wu L; Chen ZM
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):347-352. PubMed ID: 29783820
    [No Abstract]   [Full Text] [Related]  

  • 16. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.
    Ratjen F; Rietschel E; Griese M; Ballmann M; Kleinau I; Döring G; Reinhardt D; Paul K
    Eur Respir J; 2000 Jan; 15(1):141-5. PubMed ID: 10678636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.
    Ronchetti K; Tame JD; Paisey C; Thia LP; Doull I; Howe R; Mahenthiralingam E; Forton JT
    Lancet Respir Med; 2018 Jun; 6(6):461-471. PubMed ID: 29778403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
    Meyer KC; Zimmerman J
    J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells.
    Giacalone VD; Giraldo DM; Silva GL; Hosten J; Peng L; Guglani L; Tirouvanziam R
    Front Immunol; 2023; 14():1194253. PubMed ID: 37809107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10.
    Dosanjh AK; Elashoff D; Robbins RC
    J Interferon Cytokine Res; 1998 Oct; 18(10):851-4. PubMed ID: 9809620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.